Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Neuronal nitric oxide synthase (nNOS), also known as NOS I, is an enzyme responsible for the synthesis of nitric oxide (NO) in neurons. NO acts as a gaseous signaling molecule with diverse roles in the central and peripheral nervous systems. nNOS activity is calcium/calmodulin-dependent; it catalyzes the oxidation of L-arginine to produce NO and citrulline when activated by increased intracellular Ca²⁺ levels following NMDA receptor stimulation. Altered nNOS function has been implicated in various neurological disorders due to its role in synaptic signaling, neurodevelopmental processes, cardiovascular regulation, oxidative stress response in myocardium, heart failure prevention, basal blood flow maintenance, and autonomic cardiac control.
Inhibition of nitric oxide production by blocking the oxidation of L-arginine.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nitric Oxide Synthase, Neuronal (nNOS).